Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seaside Therapeutics, Inc.
Age
6–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have completed all scheduled visits in protocol 22003 and have shown they can adequately follow the protocol, with sufficient medical justification to continue on open-label treatment with STX209, as assessed by the principal investigator
You may not be if
Subjects with a medical condition that might interfere with the conduct of the study, confound interpretation of the study results, or endanger their own well-being.
The occurrence or continuation of any adverse event or condition during study 22003 that, in the opinion of the Investigator, should exclude the subject from participating in this open-label extension
Clareo Health | An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders
